FDA recall Z-0457-2022

DiaSorin Molecular LLC · Class II · device

Product

Simplexa Direct Amplification Disc Kit, Product Kit Code MOL1455

Reason for recall

A subset of affected discs are at risk of leakage when it is used more than one time with Simplexa COVID-19 Direct and/or Simplexa Flu A/B & RSV Direct Gen II. Leakage from a well that had a positive sample may cause further cross-contamination in areas of the lab if not properly cleaned.

Distribution

US: AZ, CA, CO, CT, DC, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, NC, ND, NE, NH, NJ, NM, NV, NY, OH, PA, RI, SC, SD, TN, TX, VA, VT, WA, WI, WV; and Worldwide: Kuwait, Australia, Israel, Italy, Canada, Chile, Puerto Rico, United Arab Emirates.

Key facts

Status
Ongoing
Initiation date
2021-11-19
Report date
2022-01-12
Voluntary/Mandated
Voluntary: Firm initiated
Location
Cypress, CA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0457-2022